Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 112,000 | |||
10 mg | 在庫あり | ¥ 172,500 | |||
25 mg | 在庫あり | ¥ 337,500 | |||
50 mg | 在庫あり | ¥ 581,000 | |||
100 mg | 在庫あり | ¥ 911,500 |
説明 | Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis. |
別名 | CGT9486, PLX 9486 |
分子量 | 331.37 |
分子式 | C19H17N5O |
CAS No. | 1616385-51-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 70 mg/mL (211.24 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bezuclastinib 1616385-51-3 Tyrosine Kinase/Adaptors c-Kit CGT9486 PLX 9486 Inhibitor inhibitor inhibit